Thousands of lung cancer patients may have died unnecessarily as a result of lockdown measures imposed during the COVID-19 pandemic, a new report has said. In a report published on Thursday, the UK Lung Cancer Coalition (UKLCC) said that improvements in survival rates that were occurring before the pandemic are now in jeopardy. It estimates that delays in diagnosis caused by lockdown measures may result in a drop of up to 5.3 percent in five-year survival in England, from 17.6 percent for patients diagnosed between 2014 and 2018, to around 12.3 percent for those diagnosed during the CCP (Chinese Communist Party) virus pandemic. This could lead to more than 2,500 extra deaths in the UK, the report said. Professor Robert Rintoul, chair of the UKLCC’s clinical advisory group, said: “Prior to the pandemic, real progress was being made in raising five-year survival rates. But COVID-19 has had a devastating impact …